SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-009281
Filing Date
2018-11-13
Accepted
2018-11-13 16:45:19
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aptx-20180930x10q.htm 10-Q 1789635
2 EX-31.1 aptx-20180930ex31117cdcc.htm EX-31.1 14785
3 EX-31.2 aptx-20180930ex31208db6b.htm EX-31.2 19453
4 EX-32.1 aptx-20180930ex32170b1ba.htm EX-32.1 15311
  Complete submission text file 0001558370-18-009281.txt   4860543

Data Files

Seq Description Document Type Size
5 EX-101.INS aptx-20180930.xml EX-101.INS 832463
6 EX-101.SCH aptx-20180930.xsd EX-101.SCH 30012
7 EX-101.CAL aptx-20180930_cal.xml EX-101.CAL 32444
8 EX-101.DEF aptx-20180930_def.xml EX-101.DEF 122569
9 EX-101.LAB aptx-20180930_lab.xml EX-101.LAB 257708
10 EX-101.PRE aptx-20180930_pre.xml EX-101.PRE 223386
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38535 | Film No.: 181178659
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1